Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
about
Dietary interventions for prevention of dementia in people with mild cognitive impairmentExercise interventions for preventing dementia or delaying cognitive decline in people with mild cognitive impairment18F PET ligands for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disordersPeriodontal disease's contribution to Alzheimer's disease progression in Down syndromeA/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersToward precision medicine in neurological diseasesWhat can imaging tell us about cognitive impairment and dementia?Drug Development in Alzheimer's Disease: The Contribution of PET and SPECTThe dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γExercise-Related Changes of Networks in Aging and Mild Cognitive Impairment BrainOlfactory dysfunction in Alzheimer's diseaseEarly Dementia ScreeningExpanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted ApproachesSuspected non-Alzheimer disease pathophysiology--concept and controversyThe past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular eventsFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsOverestimating the Effects of Healthy AgingCurrent Developments in Dementia Risk Prediction Modelling: An Updated Systematic ReviewAnti-dementia medications: current prescriptions in clinical practice and new agents in progressImpact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal VariationPost-stroke cognitive impairment: epidemiology, mechanisms and managementBiomarkers in dementia: clinical utility and new directionsDrug development in Alzheimer's disease: the path to 2025Expanding the phenotypic associations of globular glial tau subtypes.Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech.Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and DementiaStructural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future PerspectivesDementia.Digital technologies for cognitive assessment to accelerate drug development in Alzheimer's diseaseDementia: timely diagnosis and early interventionPersonalized health care beyond oncology: new indications for immunoassay-based companion diagnosticsFlorbetaben for PET Imaging of Beta-Amyloid Plaques in the BrainDiagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysisA Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling.Automatic speech analysis for the assessment of patients with predementia and Alzheimer's disease.Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer.Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease.
P2860
Q24186832-E1C8C600-E32B-459F-BB79-C4F152EB3BA0Q24188208-BD70C304-C3E0-4724-B9FE-0F5342EED4A8Q26472008-452E3A61-3133-4FDB-8BD6-5B506F8CF910Q26741861-23949475-AB6D-40D6-B8B4-E61EF04158BAQ26744852-7504F348-362E-4629-AE92-D4CADEA684AFQ26745508-C55D880D-FD7B-43A3-A478-CEB5BA92D7FFQ26748951-11298532-7F7C-47E1-89B5-CACED066041CQ26749292-A4A9C9FC-8DF5-425F-9565-EE7CA5CED2EBQ26749755-FA3AEFE7-48EC-45C8-8D8A-C088BC21287FQ26750987-DC3C8B90-6FB3-40FE-8781-3AD4AA7AEAD6Q26751170-5C9A6BEA-8BD6-4CD1-8DFF-CBFC34E88957Q26752969-98823477-EA09-418D-9C01-190674E49653Q26770171-4EAD1B2A-6FC4-4C3C-810C-78A412D6C8E3Q26770708-34163DE9-F61D-4EB1-B85F-E89159AC7B55Q26771270-D18147C1-2096-4AF2-88A7-B52F294A246EQ26781635-70915636-D0DD-4C97-AB96-68C64211C845Q26784569-1E5A76B2-0870-449B-AFEC-82486A12813AQ26785333-E8AEF04E-9887-4EC2-BE30-94D6A39FE3B3Q26786212-17F784DF-EF36-4BDC-91D5-664458A45C85Q26795400-445B5522-D760-4A1E-AC93-FE0075A6F77BQ26801629-D844B93B-1DA3-4F0B-80E8-0E9A4FAA7E52Q26801663-9B87EA16-9381-4E27-A5D4-6BA7817325F5Q26865422-5A7BC55E-C7DF-47BE-B349-A7EF05C0B534Q27007086-7B6FDC37-BFDB-4F2B-A39F-C212D00FCD26Q27007748-25990A88-480B-4942-9032-A2CE0AA4CC7CQ27315448-EE1A7FE8-0440-4829-AD48-E62F3ACC2612Q27317202-C3194031-435E-4E69-8CE0-C52085F62B9AQ27333816-AF82B115-C425-401A-BB66-A4A5ECCF2D19Q28067460-C04ADE0D-F0AE-40D7-A389-30E9168EB632Q28077809-31A3F933-6FE3-460B-B52A-91DBFCEA06BCQ28081075-55BF02ED-D4F3-4C64-A33C-A63190999081Q28081484-5A98D505-6472-44A0-AFBA-F141341F1CE8Q28082444-2603FDE6-E833-4CEA-A664-86A68F61423EQ28084590-E21FDEA8-4580-4D0E-9B4C-74D6CBA7E6DCQ28085541-55AF782C-8DE5-4682-AA47-C4E2CF2270E1Q28088506-3CF4E1C8-2784-4C9B-AE37-7284E82A0086Q30235315-3BFCEAB6-B416-4195-8C08-B3D2E2061ED9Q30382857-66F1B944-6430-484B-AC3C-778FC5D3E544Q30403393-1CA81852-5BBA-4E9E-A43D-3920ECAF6739Q30580280-586C808F-3F21-4E5F-97A7-C6163F7870BE
P2860
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
@ast
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
@en
type
label
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
@ast
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
@en
prefLabel
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
@ast
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
@en
P2093
P50
P1433
P1476
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
@en
P2093
Christopher Rowe
Claudia Jacova
Dennis Selkoe
Douglas Galasko
Gregory A Jicha
Lon Schneider
Marie Sarazin
Marie-Odile Habert
Nick C Fox
Philippe Robert
P304
P356
10.1016/S1474-4422(14)70090-0
P50
P577
2014-06-01T00:00:00Z